| Model Number |
3L79-21 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
02/29/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
|
| |
|
Event or Problem Description
|
|
The customer reported a falsely elevated calcium result generated on the architect c4000 on one patient.Results provided: (b)(6) = 15.1 / 10.1 mg/dl (normal range: 8.4-10.4 mg/dl).No impact to patient management was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
The evaluation of complaint data for the product and likely cause lot 07310un19 identified normal complaint activity and there are no trends for the product related to patient results.No customer returns were available for evaluation.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.An analyzer log review was performed and discovered that the customer's issue with calcium occurred while also processing the architect hba1c assay.After editing the smart wash configuration for the calcium, the customer has had no more issues.Based on the investigation no product deficiency was identified for the architect calcium assay lot# 07310un19.
|
| |
|
Search Alerts/Recalls
|